Literature DB >> 8827506

Carriage of Staphylococcus aureus in the elderly.

R M Parnaby1, G O'Dwyer, H A Monsey, M S Shafi.   

Abstract

The point prevalence and incidence of Staphylococcus aureus (methicillin-sensitive and -resistant) carriage by inpatients on acute elderly care wards was estimated. The relationship to body site and to previous admissions to hospital or other institutions was determined. Fifty-five patients were included in the point prevalence study and 136 in the incidence study, which was performed over a two-month period. One in three patients carried S. aureus and 1 in 20 was infected. The incidence rate for MRSA was 2.9%. No endemic strain was found. Nostrils were significantly associated with carriage, and skin break isolates were significant in the point prevalence survey. Screening these sites alone would be most cost effective.

Entities:  

Mesh:

Year:  1996        PMID: 8827506     DOI: 10.1016/s0195-6701(96)90003-1

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  Maggot Therapy: The Science and Implication for CAM Part I-History and Bacterial Resistance.

Authors:  Yamni Nigam; Alyson Bexfield; Stephen Thomas; Norman Arthur Ratcliffe
Journal:  Evid Based Complement Alternat Med       Date:  2006-05-05       Impact factor: 2.629

2.  The role of patients and healthcare workers Staphylococcus aureus nasal colonization in occurrence of surgical site infection among patients admitted in two centers in Tanzania.

Authors:  Nyambura Moremi; Heike Claus; Ulrich Vogel; Stephen E Mshana
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-17       Impact factor: 4.887

3.  Antibiotic Resistance of Commensal Staphylococcus aureus and Coagulase-Negative Staphylococci in an International Cohort of Surgeons: A Prospective Point-Prevalence Study.

Authors:  Mario Morgenstern; Christoph Erichsen; Simon Hackl; Julia Mily; Matthias Militz; Jan Friederichs; Sven Hungerer; Volker Bühren; T Fintan Moriarty; Virginia Post; R Geoff Richards; Stephen L Kates
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.